Terms: = Leukemia AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
38 results:
1. cxcr4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study.
Xue X; Wen Z; Zhang X; Yang Y; Li Y; Liao R; Zheng Q; Fu Y; Liu Y; Liao H
Genes Immun; 2024 Apr; 25(2):117-123. PubMed ID: 38366101
[TBL] [Abstract] [Full Text] [Related]
2. Research Progress of cxcr4-Targeting Radioligands for Oncologic Imaging.
Wang Y; Gao F
Korean J Radiol; 2023 Sep; 24(9):871-889. PubMed ID: 37634642
[TBL] [Abstract] [Full Text] [Related]
3. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
Au TY; Arudkumar J; Assavarittirong C; Benjamin S
Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
[TBL] [Abstract] [Full Text] [Related]
4. cxcr4 mediates leukemic cell migration and survival in the testicular microenvironment.
Skroblyn T; Joedicke JJ; Pfau M; Krüger K; Bourquin JP; Izraeli S; Eckert C; Höpken UE
J Pathol; 2022 Sep; 258(1):12-25. PubMed ID: 35522562
[TBL] [Abstract] [Full Text] [Related]
5. Cell surface expression of GRP78 and cxcr4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics.
Angeles-Floriano T; Rivera-Torruco G; García-Maldonado P; Juárez E; Gonzalez Y; Parra-Ortega I; Vilchis-Ordoñez A; Lopez-Martinez B; Arriaga-Pizano L; Orozco-Ruíz D; Torres-Nava JR; Licona-Limón P; López-Sosa F; Bremer A; Alvarez-Arellano L; Valle-Rios R
Sci Rep; 2022 Feb; 12(1):2322. PubMed ID: 35149705
[TBL] [Abstract] [Full Text] [Related]
6. Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact.
Krzisch D; Guedes N; Boccon-Gibod C; Baron M; Bravetti C; Davi F; Armand M; Smagghe L; Caron J; Bernard OA; Susin S; Chapiro E; Leblond V; Nguyen-Khac F; Roos-Weil D;
Am J Hematol; 2021 Dec; 96(12):1569-1579. PubMed ID: 34462944
[TBL] [Abstract] [Full Text] [Related]
7. Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia.
Ferdowsi S; Ghaffari SH; Shiraji ST; Mousavi SA; Mohammadi S
Med Oncol; 2021 Jul; 38(9):102. PubMed ID: 34313836
[TBL] [Abstract] [Full Text] [Related]
8. Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression.
Stetson LC; Balasubramanian D; Ribeiro SP; Stefan T; Gupta K; Xu X; Fourati S; Roe A; Jackson Z; Schauner R; Sharma A; Tamilselvan B; Li S; de Lima M; Hwang TH; Balderas R; Saunthararajah Y; Maciejewski J; LaFramboise T; Barnholtz-Sloan JS; Sekaly RP; Wald DN
Leukemia; 2021 Oct; 35(10):2799-2812. PubMed ID: 34244611
[TBL] [Abstract] [Full Text] [Related]
9. cxcr4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients.
El-Sherif WT; Salah El-Din EM; Aly MM; Said MG; Nigm DA
Egypt J Immunol; 2021 Jul; 28(3):114-126. PubMed ID: 34185460
[TBL] [Abstract] [Full Text] [Related]
10. [The clinical characteristics of patients with primary plasma cell leukemia and the efficacy of novel agents and hematopoietic stem cell transplantation].
Li WJ; Wang FR; Wen L; Chen Y; Chen H; Huang XJ; Lu J
Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):801-806. PubMed ID: 32987483
[No Abstract] [Full Text] [Related]
11. Reduced cxcr4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis.
Barosi G; Rosti V; Catarsi P; Villani L; Abbà C; Carolei A; Magrini U; Gale RP; Massa M; Campanelli R
Leukemia; 2021 Feb; 35(2):468-475. PubMed ID: 32536689
[TBL] [Abstract] [Full Text] [Related]
12. IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features.
Sidana S; Larson DP; Greipp PT; He R; McPhail ED; Dispenzieri A; Murray DL; Dasari S; Ansell SM; Muchtar E; Gonsalves WI; Kourelis TV; Ramirez-Alvarado M; Kapoor P; Rajkumar SV; Lacy MQ; Buadi FK; Leung N; Kyle RA; Kumar SK; King RL; Gertz MA
Leukemia; 2020 May; 34(5):1373-1382. PubMed ID: 31780812
[TBL] [Abstract] [Full Text] [Related]
13. What is new in the treatment of Waldenstrom macroglobulinemia?
Castillo JJ; Treon SP
Leukemia; 2019 Nov; 33(11):2555-2562. PubMed ID: 31591468
[TBL] [Abstract] [Full Text] [Related]
14. Bone marrow recovery of hematopoietic stem cells and microenvironment after chemotherapy in childhood acute lymphoblastic leukemia: consecutive observations according to chemotherapy schedule.
Park SH; Lee MJ; Park CJ; Jang S; Seo EJ; Im HJ; Seo JJ
Pediatr Hematol Oncol; 2019 May; 36(4):222-235. PubMed ID: 31313940
[TBL] [Abstract] [Full Text] [Related]
15. Pharmacological modulation of cxcr4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.
Recasens-Zorzo C; Cardesa-Salzmann T; Petazzi P; Ros-Blanco L; Esteve-Arenys A; Clot G; Guerrero-Hernández M; Rodríguez V; Soldini D; Valera A; Moros A; Climent F; González-Barca E; Mercadal S; Arenillas L; Calvo X; Mate JL; Gutiérrez-García G; Casanova I; Mangues R; Sanjuan-Pla A; Bueno C; Menéndez P; Martínez A; Colomer D; Tejedor RE; Teixidó J; Campo E; López-Guillermo A; Borrell JI; Colomo L; Pérez-Galán P; Roué G
Haematologica; 2019 Apr; 104(4):778-788. PubMed ID: 29954928
[TBL] [Abstract] [Full Text] [Related]
16. Microenvironment-induced PIM kinases promote cxcr4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.
Białopiotrowicz E; Górniak P; Noyszewska-Kania M; Puła B; Makuch-Łasica H; Nowak G; Bluszcz A; Szydłowski M; Jabłonska E; Piechna K; Sewastianik T; Polak A; Lech-Marańda E; Budziszewska BK; Wasylecka-Juszczyńska M; Borg K; Warzocha K; Czardybon W; Gałęzowski M; Windak R; Brzózka K; Juszczyński P
J Cell Mol Med; 2018 Jul; 22(7):3548-3559. PubMed ID: 29665227
[TBL] [Abstract] [Full Text] [Related]
17. Detection of MYD88 L265P and whim-like cxcr4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract] [Full Text] [Related]
18. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract] [Full Text] [Related]
19. Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia.
Karakurt N; Aksu T; Koksal Y; Yarali N; Tunc B; Uckan-Cetinkaya D; Ozguner M
Hematology; 2016 Jul; 21(6):325-31. PubMed ID: 26901808
[TBL] [Abstract] [Full Text] [Related]
20. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract] [Full Text] [Related]
[Next]
